Dermal Structure and Collagens
The dermis constitutes the principal structural component of human skin, providing mechanical strength, elasticity, and a scaffold for the vascular, neural, and appendageal structures that sustain epidermal viability. Unlike the epidermis, the dermis is largely acellular, consisting primarily of extracellular matrix (ECM) produced by fibroblasts. Understanding dermal architecture at the molecular level is essential for interpreting the pathophysiology of connective tissue disorders, wound healing, and cutaneous aging. The dermis comprises approximately 70-80% collagen by dry weight, with the remainder consisting of elastic fibers, proteoglycans, and other structural proteins. This organization has been refined over millions of years to provide the optimal balance between mechanical resistance and flexibility required for the skin's barrier and protective functions.
Anatomical Organization of the Dermis
Papillary Dermis
The papillary dermis is the superficial layer immediately beneath the basement membrane zone, extending into the epidermal rete ridges as dermal papillae. This layer comprises approximately 10% of the total dermal thickness.
Structural characteristics:
- Thin, loosely arranged collagen fibrils (primarily types I and III)
- Fine elastic fibers (oxytalan and elaunin fibers) extending perpendicular to the DEJ
- High vascularity: Capillary loops within dermal papillae deliver nutrients to the avascular epidermis
- Abundant ground substance: Glycosaminoglycans and proteoglycans
- Cellular elements: Fibroblasts, mast cells, dermal dendritic cells
Clinical correlate: The dermal papillae create the fingerprint patterns (dermatoglyphics) visible on the palmar and plantar surfaces. Lichen planus characteristically demonstrates saw-tooth (irregular) acanthosis with wedge-shaped hypergranulosis and a band-like lymphocytic infiltrate obscuring the DEJ within the papillary dermis.
Reticular Dermis
The reticular dermis constitutes approximately 90% of the total dermal thickness and extends from the papillary dermis to the subcutaneous fat.
Structural characteristics:
- Thick, densely packed collagen bundles arranged in a basket-weave pattern
- Mature elastic fibers oriented horizontally, interconnecting with vertical extensions
- Fewer cells relative to ECM volume
- Houses skin appendages: Hair follicles, sebaceous glands, eccrine/apocrine glands
- Contains larger blood vessels and nerves
Clinical correlate: Scarring primarily involves the reticular dermis. Keloids extend beyond the original wound margins with abundant, disorganized collagen bundles. Hypertrophic scars remain within wound boundaries but show similarly excessive collagen deposition.
Collagen: Dominant ECM Component
Collagen comprises approximately 70-80% of the dry weight of the dermis. The collagen superfamily includes 29 genetically distinct types in vertebrate tissues, many of which are present in human skin.
Classification of Dermal Collagens
| Class | Types | Supramolecular Assembly | Key Features |
|---|---|---|---|
| Fibrillar | I, III, V | Large cross-striated fibrils | 640 Å banding pattern, quarter-stagger array |
| Network-forming | IV, VIII | Interlacing network | Basement membranes |
| Microfibrillar | VI | Independent microfibrils | Anchoring function |
| Anchoring fibril | VII | U-shaped anchoring fibrils | Sublamina densa |
| Transmembrane | XIII, XVII | Type 2 orientation | Hemidesmosomes, focal adhesions |
| FACIT | IX, XII, XIV, XIX, XX, XXI | Fibril-associated | Molecular bridges |
Type I Collagen
Type I collagen is the most abundant collagen in human dermis, accounting for approximately 80% of total dermal collagen.
Clinical appearance: Type I collagen provides skin tensile strength, resistance to stretching, and structural integrity visible clinically as normal skin texture and elasticity.
Histological characteristics: On H&E staining, Type I collagen appears as thick, eosinophilic (pink) fibers arranged in wavy bundles in the reticular dermis. With trichrome stains, Type I collagen shows blue or green coloration and exhibits parallel fiber arrangement that straightens under tension.
Dermoscopic correlation: Dense Type I collagen creates the white background color in dermoscopy, providing structural support for other dermoscopic features. In conditions affecting collagen (aging, sclerosis), dermoscopy shows altered white patterns and loss of normal structural organization.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(I)]₂α2(I) — two α1 chains, one α2 chain |
| Genes | COL1A1 (17q21.33), COL1A2 (7q21.3) |
| Molecule length | ~300 nm |
| Molecular weight | ~285 kDa (procollagen ~450 kDa) |
| Triple helix | Glycine-X-Y repeating sequence; glycine in every third position |
| Hydroxyproline content | ~10% of amino acids (stabilizes triple helix) |
| Hydroxylysine content | ~1% (required for cross-links) |
Assembly into Fibrils
Type I collagen molecules align in a quarter-stagger array, with each molecule displaced by approximately 67 nm (one D-period) relative to its neighbor. This arrangement produces the characteristic 640 Å (64 nm) banding pattern visible by transmission electron microscopy.
The quarter-stagger array creates alternating "gap" and "overlap" zones:
- Gap zones: Spaces between the ends of adjacent molecules (~35 nm)
- Overlap zones: Regions where molecules overlap (~29 nm)
Clinical significance: In osteogenesis imperfecta, glycine substitutions in the triple-helical domain prevent proper helix formation. The position of the mutation along the helix correlates with severity—mutations closer to the C-terminus are more severe due to C-to-N propagation of helix formation.
Type I Collagen and Disease
| Disease | Gene | Mutation Type | Mechanism |
|---|---|---|---|
| Osteogenesis imperfecta type I | COL1A1 | Null allele | Haploinsufficiency — 50% normal collagen |
| Osteogenesis imperfecta types II-IV | COL1A1, COL1A2 | Glycine substitutions | Dominant-negative — abnormal molecules incorporated into fibrils |
| EDS arthrochalasia type (VIIA, VIIB) | COL1A1, COL1A2 | Exon 6 skipping | Loss of N-propeptide cleavage site |
Type III Collagen
Type III collagen comprises approximately 10% of adult dermal collagen but is the dominant collagen during embryonic development and early wound healing.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(III)]₃ — homotrimer |
| Gene | COL3A1 (2q32.2) |
| Distribution | Blood vessels, GI tract, uterus, skin |
| Type I:III ratio | ~8:1 in adult dermis |
Developmental Regulation
During embryonic development, type III collagen predominates. Postnatally, type I collagen synthesis accelerates, establishing the characteristic adult ratio. In wound healing, type III collagen is initially deposited in granulation tissue, then gradually replaced by type I collagen during scar maturation (remodeling phase, 6-12+ months).
Ehlers-Danlos Syndrome Vascular Type (Type IV)
The most dangerous EDS subtype — arterial, intestinal, and uterine rupture.
| Feature | Details |
|---|---|
| Gene | COL3A1 |
| Inheritance | Autosomal dominant |
| Mutation types | Glycine substitutions (most severe), splice-site, haploinsufficiency |
| Mechanism | Dominant-negative: mutant α1(III) chains incorporate into homotrimers → structural weakness |
| Median survival | ~50 years |
| Cause of death | Arterial rupture (especially medium-sized arteries), sigmoid perforation, uterine rupture in pregnancy |
| Skin findings | Thin, translucent skin; visible veins; minimal wrinkling; acrogeria (aged appearance of hands/feet) |
| Minor criteria | Easy bruising, spontaneous pneumothorax, early-onset varicose veins |
Pathognomonic clinical feature: Thin, translucent skin with visible subcutaneous vessels, particularly over the chest and abdomen.
Type V Collagen
Type V collagen represents less than 5% of total dermal collagen but plays a critical regulatory role in fibril diameter control.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | [α1(V)]₂α2(V) — major form; additional α3(V) and α4(V) chains exist |
| Genes | COL5A1 (9q34.3), COL5A2 (2q32.2) |
| Location | Surface of large collagen fibrils |
| Function | Regulates lateral growth of type I collagen fibrils |
Fibril Diameter Regulation
Type V collagen molecules are positioned on the surface of type I/III collagen fibrils. The retained N-propeptide of α1(V) chains projects outward and sterically hinders further lateral aggregation, thus limiting fibril diameter.
In the absence of type V collagen:
- Fibril diameters become variable and irregular
- Cross-sections show "flower-like" morphology (irregular contours)
- Connective tissue mechanical integrity is compromised
Ehlers-Danlos Syndrome Classic Type (Types I and II)
| Feature | Details |
|---|---|
| Genes | COL5A1 (most common), COL5A2, rarely COL1A1 |
| Inheritance | Autosomal dominant |
| Mechanism | Haploinsufficiency — 50% reduction in type V collagen production |
| Skin hyperextensibility | Skin extends beyond normal limits but recoils (unlike cutis laxa) |
| Joint hypermobility | Beighton score ≥5/9 |
| Tissue fragility | "Cigarette paper" (papyraceous) scarring, atrophic scars |
| Molluscoid pseudotumors | Fleshy lesions over pressure points |
| Subcutaneous spheroids | Calcified fat lobule herniation, palpable |
Skin biopsy findings: Electron microscopy demonstrates irregular collagen fibril diameters and "flower-like" cross-sections.
Type VI Collagen
Type VI collagen forms an independent microfibrillar network distinct from the large collagen fibrils.
Molecular Structure
| Property | Value |
|---|---|
| Chain composition | α1(VI)α2(VI)α3(VI) — heterotrimer with additional α4-α6 chains described |
| Genes | COL6A1 (21q22.3), COL6A2 (21q22.3), COL6A3 (2q37.3) |
| Structure | Short triple helix (~105 nm) flanked by large globular domains |
| Supramolecular assembly | Beaded microfibrils (~105 nm periodicity) |
Function
Type VI collagen microfibrils serve an anchoring function, stabilizing:
- Collagen fibril assembly
- Basement membrane attachment to underlying matrix
- Cell-matrix interactions via integrin α1β1 and α2β1 binding
Clinical Correlations
Mutations in COL6A1, COL6A2, and COL6A3 cause congenital muscular dystrophies with minimal cutaneous phenotype:
- Ullrich congenital muscular dystrophy (severe, AR)
- Bethlem myopathy (mild, AD)
The relatively mild skin manifestations in these disorders reflect the redundancy of dermal ECM components.
Collagen Biosynthesis
Collagen synthesis is a complex, multi-step process involving intracellular post-translational modifications and extracellular processing.
Biosynthetic Pathway
Loading diagram...
Key Enzymes in Collagen Biosynthesis
| Enzyme | Gene(s) | Cofactors | Function | Disease if Deficient |
|---|---|---|---|---|
| Prolyl 4-hydroxylase | P4HA1, P4HA2, P4HB | Fe²⁺, α-KG, O₂, ascorbate | 4-hydroxyproline formation → helix stability | Scurvy |
| Lysyl hydroxylase 1 | PLOD1 | Fe²⁺, α-KG, O₂, ascorbate | Hydroxylysine formation → cross-links | EDS kyphoscoliotic (VI) |
| Lysyl hydroxylase 2 | PLOD2 | Same | Telopeptide hydroxylation | Bruck syndrome |
| Lysyl hydroxylase 3 | PLOD3 | Same | Glucosyltransferase activity also | Connective tissue disorder |
| ADAMTS2 | ADAMTS2 | Zn²⁺ | N-propeptide cleavage (types I, II, III) | EDS dermatosparaxis (VIIC) |
| BMP-1/Tolloid | BMP1 | Zn²⁺ | C-propeptide cleavage | Not established |
Prolyl Hydroxylation and Scurvy
Prolyl 4-hydroxylase catalyzes the hydroxylation of proline residues in the Y position of the Gly-X-Y sequence:
Proline + O₂ + α-ketoglutarate → 4-Hydroxyproline + CO₂ + Succinate
Ascorbic acid (vitamin C) is required to maintain the iron cofactor in its reduced (Fe²⁺) state. In scurvy (ascorbate deficiency):
- Prolyl hydroxylation is impaired
- Underhydroxylated collagen has lower melting temperature (Tm)
- Triple helix is unstable at body temperature (37°C)
- Clinical manifestations: Poor wound healing, gingival bleeding, perifollicular hemorrhages, corkscrew hairs
Collagen Cross-Linking
The tensile strength of collagen fibrils depends on covalent intermolecular cross-links formed by lysyl oxidase.
Lysyl Oxidase Family
| Enzyme | Gene | Key Features |
|---|---|---|
| Lysyl oxidase (LOX) | LOX | Classic enzyme; requires copper cofactor |
| LOXL1 | LOXL1 | Exfoliation glaucoma susceptibility |
| LOXL2 | LOXL2 | Cancer biology, fibrosis |
| LOXL3 | LOXL3 | Craniofacial development |
| LOXL4 | LOXL4 | Cartilage |
Cross-Linking Mechanism
Loading diagram...
Cross-Link Types
| Cross-Link | Type | Location | Stability |
|---|---|---|---|
| Dehydro-lysinonorleucine | Divalent | Skin, tendon | Immature, reducible |
| Dehydro-hydroxylysinonorleucine | Divalent | Skin, tendon | Immature, reducible |
| Pyridinoline (hydroxylysyl-pyridinoline) | Trivalent | Bone, cartilage, dermis | Mature, non-reducible |
| Deoxypyridinoline (lysyl-pyridinoline) | Trivalent | Bone, dentin | Mature, non-reducible |
Copper Deficiency and Cross-Linking
Lysyl oxidase requires copper as a cofactor. Copper deficiency impairs cross-linking:
| Condition | Gene | Mechanism | Clinical Features |
|---|---|---|---|
| Menkes syndrome | ATP7A | Defective copper absorption → systemic copper deficiency | Kinky hair, neurodegeneration, connective tissue laxity |
| Occipital horn syndrome | ATP7A | Allelic, milder | Occipital exostoses, bladder diverticula, skin laxity |
| Nutritional copper deficiency | — | Dietary | Rare; impaired wound healing |
| D-penicillamine toxicity | — | Copper chelation | Drug-induced cutis laxa |
Collagen Degradation: Matrix Metalloproteinases
The matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade ECM components.
MMP Classification
| Class | MMPs | Primary Substrates |
|---|---|---|
| Collagenases | MMP1, MMP8, MMP13 | Fibrillar collagens I, II, III |
| Gelatinases | MMP2, MMP9 | Gelatin, collagen IV, V, VII |
| Stromelysins | MMP3, MMP10, MMP11 | Proteoglycans, laminin, collagen IV |
| Matrilysins | MMP7, MMP26 | ECM components, pro-MMPs |
| Membrane-type | MMP14-17, MMP24 | Pro-MMP2, pericellular collagenolysis |
MMP1 (Interstitial Collagenase)
MMP1 is the prototypic interstitial collagenase, synthesized by fibroblasts and keratinocytes.
Cleavage specificity:
- α1(I) chain: Cleaves at Gly⁷⁷⁵-Ile⁷⁷⁶
- α2(I) chain: Cleaves at Gly⁷⁷⁵-Leu⁷⁷⁶
This single cleavage produces ¾ and ¼ fragments. These fragments have a lower Tm and spontaneously denature at 37°C, becoming susceptible to non-specific proteases (gelatinases).
MMP Regulation
| Level | Mechanism |
|---|---|
| Transcriptional | Cytokines (IL-1, TNF-α), growth factors, AP-1, NF-κB |
| Pro-enzyme activation | Proteolytic cleavage of N-terminal propeptide |
| Inhibition | TIMPs 1-4 (stoichiometric, 1:1 binding) |
| Pharmacological inhibition | Tetracyclines (chelate Ca²⁺/Zn²⁺), synthetic inhibitors |
TIMPs (Tissue Inhibitors of Metalloproteinases)
| TIMP | Primary MMP Targets | Key Features |
|---|---|---|
| TIMP-1 | MMP1, MMP3, MMP9 | Broadly inhibitory |
| TIMP-2 | MMP2, MT-MMPs | Also required for pro-MMP2 activation |
| TIMP-3 | MMPs, ADAMs, ADAMTSs | Bound to ECM |
| TIMP-4 | MMP2, MT1-MMP | Heart, brain |
MMPs in Dermatology
| Condition | MMP Involvement |
|---|---|
| Photoaging | MMP1, MMP3, MMP9 upregulated by UV → collagen degradation |
| Wound healing | MMPs essential for keratinocyte migration, ECM remodeling |
| Bullous diseases | MMP9 in BP blister fluid; gelatinases in tissue separation |
| Tumor invasion | MMP2, MMP9 facilitate basement membrane degradation |
| Recessive dystrophic EB | Loss of collagen VII → MMP-mediated dermal fibrosis, SCC development |
Osteogenesis Imperfecta: Type I Collagen Genetic Disorders
Osteogenesis imperfecta (OI) comprises a family of heritable connective tissue disorders affecting type I collagen synthesis or processing, characterized by skeletal fragility, dental abnormalities, and cutaneous features.
Molecular Classification and Mechanisms
Type I OI (90% of cases, mild):
- Gene: COL1A1 (chromosome 17q21.33)
- Mutation: Null allele (deletion, premature termination, splice-site mutation)
- Pathomechanism: Haploinsufficiency — 50% reduction in type I collagen quantity with normal structure
- Phenotype: Blue sclerae, hearing loss, bone fragility after age 30, minimal tooth involvement
- Cutaneous findings: Normal skin appearance, no hyperextensibility
Types II-IV OI (10-30% of cases, severe):
- Genes: COL1A1, COL1A2 (chromosome 7q21.3)
- Mutations: Glycine substitutions in the collagenous domain
- Pathomechanism: Dominant-negative — mutant α-chains incorporate into ~75% of collagen molecules, disrupting triple-helix formation (triple helix propagates C→N, so late mutations are worse)
- Phenotype severity correlates with mutation location: C-terminal mutations (type II, perinatal lethal) > mid-domain mutations (type III, progressive deformity) > N-terminal mutations (type IV, mild to moderate)
- Cutaneous findings: Type III shows hyperextensible skin similar to EDS classic, significant scarring; type IV minimal skin changes
Biochemical Consequences
Glycine substitutions disrupt the triple helix because only glycine fits in the sterically constrained interior of the helix core. Substitutions create regions of abnormal conformation, producing thermolabile triple helix (lower Tm), impaired folding, or partial incorporation into structurally weakened fibrils with irregular diameters.
Dermatopathological and Dermoscopic Features
Skin biopsy shows:
- Normal dermal architecture in mild type I
- Decreased dermal thickness in types III and IV
- TEM: Irregular collagen fibril diameters, "flower-like" cross-sections in types with glycine substitutions
- Collagen type distribution: Slightly increased type III/I ratio (normal ~0.1, OI ~0.15-0.2)
Dermoscopy shows:
- Normal features in type I
- Loss of structural dermoscopic patterns, increased transparency in types III and IV
- Branching vessels may be more prominent due to thin dermis
Scurvy: Ascorbate-Dependent Collagen Defect
Scurvy results from ascorbic acid (vitamin C) deficiency, impairing collagen hydroxylation and causing profound connective tissue failure.
Molecular Pathology
Prolyl 4-hydroxylase catalyzes:
Pro-α-chain (underhydroxylated) + O₂ + α-ketoglutarate + Fe²⁺ (reduced) → Pro-α-chain (4-hydroxyproline, ~50% of Y positions) + CO₂ + succinate
Hydroxyproline stabilizes the triple helix through additional hydrogen bonding and increases melting temperature (Tm) from 24°C (unhydroxylated) to 37°C (normal, ~10% hydroxyproline). Lysine hydroxylation generates hydroxylysine, providing sites for carbohydrate attachment (glycosylation) and cross-link formation.
Ascorbate requirement: Acts as an electron donor keeping the iron cofactor in the Fe²⁺ state. Without ascorbate:
- Iron oxidizes to Fe³⁺ (inactive)
- Hydroxylation ceases
- Pro-α-chains remain severely underhydroxylated (~2-3% hydroxyproline instead of 10%)
- Underhydroxylated collagen has Tm of 24°C — denatures at body temperature
- Fibrils become structurally incompetent → bleeding, poor wound healing, gum disease
Clinical Manifestations
- Perifollicular hemorrhages — blood extravasates around hair follicles where dermal collagen cannot support capillaries
- Bleeding gums (if teeth present) — gingival collagen defect
- Poor wound healing — collagen cannot form stable fibrils to organize granulation tissue
- Dental complications — in young children, exposed dentin hypersensitivity
- Corkscrew hairs — defective hair shaft collagen causes characteristic appearance
Dermatopathology
Histology shows:
- Minimal inflammation (unlike typical scurvy-mimicking vasculitis)
- Leakage of red blood cells in dermis (perifollicular pattern)
- Fragmented dermal collagen with poor fibril organization on TEM
Prevention and Treatment
Ascorbate requirement: ~10 mg/day minimum (RDA ~90 mg for adults). High-dose vitamin C supplementation reverses defect if caught early (weeks), though hemorrhaging scarring can be permanent.
Menkes Syndrome: Copper-Dependent Cross-Link Defect
Menkes syndrome results from mutations in ATP7A (Xq13.3, encodes a copper-transporting ATPase), causing systemic copper deficiency and cross-linking deficiency.
Molecular Mechanism
Lysyl oxidase (LOX) requires copper as a cofactor (Cu²⁺ in active site). The enzyme oxidatively deaminates lysine and hydroxylysine residues to allysine and hydroxyallysine aldehydes, initiating cross-link formation.
ATP7A mutation → defective enterocyte copper absorption → systemic copper deficiency → LOX inactivity → collagen cross-linking failure
Clinical and Cutaneous Features
- Kinky hair (pili torti) — defective hair shaft collagen and keratin cross-linking
- Depigmented hair — tyrosinase (copper-dependent enzyme) deficiency reduces melanin
- Connective tissue laxity — skin hyperextensibility (though less marked than EDS)
- Easy bruising — fragile blood vessels
- Neurological deterioration — cytochrome c oxidase (copper-dependent) deficiency in brain
- Characteristic facies — "cherub-like" with full cheeks
- Death usually by age 3 years from neurological complications
Dermatopathological Features
Collagen fibrils appear immature with small diameter and poor packing due to lack of cross-links. Cross-link quantification shows severe reduction in divalent and trivalent cross-links. Cross-sectional diameters on TEM are <50 nm (normal >100 nm).
Related Disorder: Occipital Horn Syndrome
Allelic variant of Menkes (ATP7A mutations) with:
- Milder copper deficiency (residual ATP7A function)
- Occipital bone exostoses (benign bony bumps on occipital skull)
- Bladder diverticula
- Connective tissue laxity (milder than Menkes)
- Longer survival (into adulthood)
Therapeutic Approaches
Copper supplementation or copper-histidine complex can partially restore LOX activity if started early enough, but neurological damage is often irreversible.
Ehlers-Danlos Syndromes and Related Collagen Disorders: Molecular Classification
| Type | Former Name | Gene(s) | Protein (MW, amino acids) | Inheritance | Molecular Defect | Clinical Severity |
|---|---|---|---|---|---|---|
| Classic | I, II | COL5A1 (9q34.3), COL5A2 (2q32.2), COL1A1 (17q21.3) | Type V collagen (~350 kDa), Type I (~285 kDa) | AD | Haploinsufficiency (50% reduction type V) or glycine substitutions | Mild-Moderate |
| Classic-like | — | TNXB (6p21.3) | Tenascin-X (~685 kDa, ECM protein) | AR | ECM protein loss → reduced cross-linking | Mild-Moderate |
| Cardiac Valvular | — | COL1A2 (7q21.3) | Type I collagen α2-chain | AR | Glycine substitutions → valve pathology | Moderate |
| Vascular (IV) | IV | COL3A1 (2q32.2) | Type III collagen (~285 kDa) | AD | Glycine substitutions (dominant-negative) or haploinsufficiency | SEVERE (50-year median) |
| Hypermobile (III) | III | Heterogeneous (>50% unknown) | Unknown (likely ECM-related) | AD (mostly) | Genetic basis unclear | Mild (morbidity ≠ mortality) |
| Arthrochalasia (VIIA,VIIB) | VIIA, VIIB | COL1A1, COL1A2 | Type I collagen (exon 6 skipping) | AD | N-propeptide cleavage site disrupted → unprocessed procollagen | Moderate |
| Dermatosparaxis (VIIC) | VIIC | ADAMTS2 (5q35.3) | ADAMTS2 protease (593 aa, 66 kDa) | AR | Absent N-propeptidase activity → no N-peptide removal | Moderate |
| Kyphoscoliotic (VI) | VI | PLOD1 (1q41), FKBP14 (4q22.1) | LH1 (749 aa, 86 kDa), FKBP22 | AR | Hydroxylysine deficiency (PLOD1) → failed cross-linking; OR chaperone failure (FKBP14) | Moderate-Severe |
| Brittle Cornea (IX) | — | ZNF469, PRDM5 | Zinc finger protein, PRDM5 | AR | Transcriptional regulation of collagen | Ocular-specific |
| Spondylodysplastic (X) | — | B4GALT7 (5q14.3), B3GALT6 (12q24.31), SLC39A13 (8p21.3) | Galactosyl transferase, ZIP13 zinc transporter | AR | GAG glycosylation defect (reduced galactose) → collagen cross-link failure | Moderate (skeletal) |
| Musculocontractural (XI) | — | CHST14 (3p21.31), DSE (6q12.1) | D4ST1 sulfotransferase, dermatan sulfate epimerase | AR | Dermatan sulfate deficiency → aberrant collagen arrangement | Congenital contractures |
| Myopathic (XII) | — | COL12A1 (6q12.3) | Type XII collagen (FACIT, ~470 kDa) | AD/AR | FACIT collagen scaffold → muscle attachment dysfunction | Muscle-specific |
| Periodontal (VIII) | VIII | C1R (12p13.31), C1S (12p13.31) | Complement C1r/C1s (serine protease, 250-290 kDa) | AD | Defective collagen processing (complement-mediated) | Periodontal-specific |
| Osteogenesis Imperfecta (OI) | Separate disorder | COL1A1, COL1A2 | Type I collagen | AD (mostly) | Null mutations (OI type I: haploinsufficiency); glycine substitutions (OI types II-IV: dominant-negative) | Skeletal-specific |
| Marfan Syndrome | Fibrillinopathy | FBN1 (15q21.1) | Fibrillin-1 (3,871 aa, ~350 kDa, 43 cbEGF domains) | AD | Glycine substitutions in cbEGF/8-Cys domains → fibrillin misfolding + defective TGF-β sequestration | Vascular risk |
Pathomechanical Principles
Dominant-negative mechanism (illustrated by vascular EDS):
- Mutant COL3A1 allele produces defective α1(III) chains
- Type III collagen is homotrimer ([α1(III)]₃)
- With 50% mutant chains: Probability of all 3 being mutant = 0.5³ = 12.5% of trimers are all-mutant, plus 37.5% are mixed (1-2 mutant chains)
- Mutant chains prevent proper helix formation → trimerization fails → destabilized collagen incorporated into fibrils → weak, unstable structure
- Even single glycine substitution can cause catastrophic helix disruption
Haploinsufficiency (EDS classic):
- 50% reduction in normal type V collagen quantity
- Remaining normal collagen still has normal structure but insufficient quantity
- Fibril diameters become irregular (normal ~100-300 nm, regulated by type V surface coat)
- Result: mechanical weakness without structural abnormality in remaining collagen
Integration: Three-Language Dermal Pathology
Clinical-Pathological Correlation
Thin, translucent skin (vascular EDS, classic EDS):
- Clinical: Skin appears semi-translucent, with visible subcutaneous vessels (especially over chest, abdomen)
- Histopathology: Dermal thickness markedly reduced (measured on H&E), collagen fibrils on TEM show irregular diameters, poor organization
- Dermoscopy: Loss of pigment network (due to thin dermis), prominent vascular pattern visible (subcutaneous vessels, linear or branching), loss of structural background
Atrophic ("cigarette paper") scars:
- Clinical: Paper-thin scars with white, shiny surface, often in linear pattern
- Histopathology: Scar tissue shows markedly reduced collagen density, sparse fibroblasts, thin epidermis overlying scarred dermis (collagen fibrils may be sparse or show abnormal organization on TEM)
- Dermoscopy: White background (collagen), linear arrangement, loss of normal dermal network pattern
Molluscoid pseudotumors:
- Clinical: Soft, fleshy nodules (2-5 cm) on elbows, knees, shins — result from recurrent trauma and fat hernia through damaged dermis
- Histopathology: Subcutaneous fat protruding through defective dermal collagen, often with lipoma-like architecture, surrounding dermal fibrosis
- Dermoscopy: Yellow background (lipid), irregular white streaks (fibrous tissue), may show surface scale or crust if overlying epidermis involved
Summary
The dermis is a precisely engineered collagen-based structure providing mechanical resilience while maintaining flexibility. Type I collagen (~80-85% of dermal collagen by dry weight) provides tensile strength; type III collagen (~10-15%) provides elasticity and is predominant in embryonic/early wound healing; type V collagen (~5%) regulates fibril diameter; type VI collagen provides microfibrillar anchoring. Elastic fibers (oxytalan → elaunin → mature fibers) scaffold with fibrillins, enabling tissue recoil. Collagen biosynthesis demands ascorbate-dependent hydroxylation of proline/lysine residues by P4H and LH enzymes, followed by triple-helix formation and secretion. Extracellular ADAMTS proteases cleave propeptides; lysyl oxidase initiates cross-linking via aldehyde chemistry, requiring copper cofactor. Mature fibrils undergo MMP-mediated remodeling, regulated by TIMP inhibitors. Genetic defects in collagen synthesis, processing, or cross-linking enzymes cause Ehlers-Danlos syndromes, each with distinct molecular mechanisms: type V/I haploinsufficiency (classic), type III glycine substitutions (vascular, most dangerous), type I exon 6 skipping (arthrochalasia, N-peptide cleavage failure), ADAMTS2 loss (dermatosparaxis, N-peptide absence), LH1 deficiency (kyphoscoliotic, hydroxylysine deficiency), plus disorders of fibrillins (Marfan), copper (Menkes), or ascorbate (scurvy). Understanding these molecular cascades enables prediction of clinical severity, genetic counseling, and potential future therapeutic targets.
This comprehensive section integrates embryological, molecular, genetic, histopathological, and dermoscopic perspectives on dermal structure, providing the foundational knowledge necessary for understanding skin pathology and connective tissue disease.
How to Cite
Cutisight. "Dermal Structure and Collagens." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-02-normal-skin/part-01-embryology-anatomy-histology/06-dermis/01-dermal-structure-and-collagens
This is an open-access resource. Please cite appropriately when using in academic or clinical work.